Acerta Pharma's Series A Round

Acerta Pharma raised a round of funding on March 14, 2013.

Acerta Pharma, a privately-owned biotech company that combines two technology platforms in drug discovery and development: the Covalent Technology Platform and the Multiparametric Phosphoflow Cytometr…

Articles about Acerta Pharma's Series A Round: